SSY Group ( (HK:2005) ) has issued an update.
SSY Group Limited has announced the approval for the production and registration of two new drugs by the National Medical Products Administration of China. The approvals for Tranexamic Acid Tablets and Acipimox Capsules, both classified as type 4 chemical drugs, mark significant milestones for the company, enhancing its product portfolio and potentially strengthening its market position in China.
More about SSY Group
SSY Group Limited operates in the pharmaceutical industry, focusing on the development and production of chemical drugs. The company is involved in creating medications for various health conditions, with a market focus on China.
YTD Price Performance: -1.85%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.26B
See more data about 2005 stock on TipRanks’ Stock Analysis page.